• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS ANTI-HCV II; ASSAY,ENZYME LINKED IMMUNOSORBENT,HEPATITIS C VIRUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS ANTI-HCV II; ASSAY,ENZYME LINKED IMMUNOSORBENT,HEPATITIS C VIRUS Back to Search Results
Catalog Number 08837031190
Medical Device Problem Code False Positive Result (1227)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/18/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The reported event involved the anti-hcv g2 elecsys cobas e 200 v2 assay on a cobas 6000 e601 module (serial number: (b)(6)).The investigation determined that the anti-hcv g2 elecsys assay performed within specifications based on its specificity claim of 99.85% in blood donors.A review of calibration and quality control data confirmed all results were within expected ranges, and no instrument-related issues were identified.The investigation was limited as no sample material was provided for further analysis.The observed false reactivity is most likely attributable to sample-specific interference.For the eqas sample, potential causes include preservatives or the sample production process.The root cause for the reported false reactivity could not be definitively determined.The device remains in operation at the customer site.
 
Event or Problem Description
The initial reporter alleged discrepant reactive results with the anti-hcv g2 elecsys cobas e 200 v2 assay on the cobas 6000 e601 module.A patient sample tested reactive for anti-hcv ii with a result of 10.08 coi.This was a follow-up sample collected one year after a previous sample from the same patient, which had been reported as indeterminate in an immunoblot assay.Additionally, a microbiology external quality assessment scheme (eqas) sample tested reactive for anti-hcv ii with a result of 12.61 coi on the cobas 6000 e601 module.The same eqas sample tested non-reactive (0.08 index) on competitor instruments, including abbott and ocd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS ANTI-HCV II
Common Device Name
ASSAY,ENZYME LINKED IMMUNOSORBENT,HEPATITIS C VIRUS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
natalie catton
9115 hague road
indianapolis, IN 46250
MDR Report Key23095381
Report Number1823260-2025-03170
Device Sequence Number9225315
Product Code MZO
UDI-Device Identifier07613336166970
UDI-Public07613336166970
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
K221693
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 09/19/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number08837031190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/20/2021
Initial Report FDA Received Date09/19/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
-
-